stockrowLiquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
Follow LQDA
Alert me
Liquidia Corporation (LQDA) Free cash flow
Liquidia Corporation's free cash flow for fiscal 2025 was −$40.0M, compared with −$98.4M in fiscal 2024. Over the twelve months to 30 June 2026 it was $150.7M. Over the past ten years it has ranged from −$98.4M (fiscal 2024) to −$13.9M (fiscal 2016); the current reading is higher than 44% of that period. Liquidia Corporation ranks 21st of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$40.0M | — |
| FY2024 | −$98.4M | — |
| FY2023 | −$42.9M | — |
| FY2022 | −$29.2M | — |
| FY2022 | −$28.6M | — |
| FY2021 | −$34.1M | — |
| FY2021 | −$34.0M | — |
| FY2020 | −$54.9M | — |
| FY2020 | −$54.1M | — |
| FY2019 | −$50.1M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $69.0M | 37.58% |
| Mar 2026 | $50.2M | 18.85% |
| Dec 2025 | $42.2M | — |
| Sep 2025 | −$10.7M | — |
| 33 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | $409.5M |
| PBH Prestige Consumer Healthcare Inc. compare | $214.2M |
| LQDA Liquidia Corporation | $150.7M |
| HIMS Hims & Hers Health, Inc. compare | $83.0M |
| SUPN Indivior Pharmaceuticals Inc. compare | $31.0M |
| RGC Regencell Bioscience Holdings Limited compare | −$14.7M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −$60.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$130.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | −$171.8M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on LQDA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement